Growth Metrics

Evolent Health (EVH) Free Cash Flow (2016 - 2026)

Evolent Health has reported Free Cash Flow over the past 11 years, most recently at $41.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 226.73% year-over-year to $41.0 million; the TTM value through Dec 2025 reached $4.8 million, up 177.59%, while the annual FY2025 figure was $4.8 million, 177.59% up from the prior year.
  • Free Cash Flow for Q4 2025 was $41.0 million at Evolent Health, up from $6.8 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $83.3 million in Q4 2023 and troughed at -$66.0 million in Q1 2022.
  • A 5-year average of $3.8 million and a median of $2.0 million in 2022 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 502.64% in 2023 and later plummeted 820.09% in 2025.
  • Year by year, Free Cash Flow stood at $59.4 million in 2021, then plummeted by 58.0% to $25.0 million in 2022, then soared by 233.96% to $83.3 million in 2023, then crashed by 138.86% to -$32.4 million in 2024, then soared by 226.73% to $41.0 million in 2025.
  • Business Quant data shows Free Cash Flow for EVH at $41.0 million in Q4 2025, $6.8 million in Q3 2025, and -$39.1 million in Q2 2025.